Review
doi: 10.1016/j.breast.2009.07.001.
Epub 2009 Aug 3.
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment
Affiliations
- PMID: 19651512
- DOI: 10.1016/j.breast.2009.07.001
Item in Clipboard
Review
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment
Breast.
2009 Aug.
Free article
Abstract
Osteonecrosis of the jaw (ONJ) is a rare but severe disease which has been diagnosed in women with breast cancer on a bisphosphonate (BP) therapy. Thus, the German society of senology appointed a multidisciplinary task force to establish a consensus on the use of bisphosphonates in breast cancer patients with bone metastases, considering in particular the possible risk of ONJ. This report summarizes the results and recommendations for the prevention and treatment of ONJ in breast cancer patients receiving BP.
Comment in
-
Bisphosphonate osteonecrosis of the jaws in cancer patients.Breast. 2009 Oct;18(5):335. doi: 10.1016/j.breast.2009.09.003. Epub 2009 Sep 27. Breast. 2009. PMID: 19783147 No abstract available.
Similar articles
-
Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.Cancer. 2009 Apr 15;115(8):1631-7. doi: 10.1002/cncr.24119. Cancer. 2009. PMID: 19156913
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
-
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.J Clin Oncol. 2005 Dec 1;23(34):8580-7. doi: 10.1200/JCO.2005.02.8670. J Clin Oncol. 2005. PMID: 16314620
-
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.Ann N Y Acad Sci. 2011 Feb;1218:47-54. doi: 10.1111/j.1749-6632.2010.05771.x. Epub 2010 Sep 28. Ann N Y Acad Sci. 2011. PMID: 20946574 Review.
-
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.Bone. 2008 May;42(5):841-7. doi: 10.1016/j.bone.2008.01.003. Epub 2008 Jan 18. Bone. 2008. PMID: 18314405 Review.
Cited by
-
Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort.Dent J (Basel). 2022 May 19;10(5):89. doi: 10.3390/dj10050089. Dent J (Basel). 2022. PMID: 35621542 Free PMC article.
-
Volumetric analysis of the periodontal microstructure under antiresorptive therapy: an experimental study in rabbits.Clin Oral Investig. 2022 Aug;26(8):5359-5368. doi: 10.1007/s00784-022-04503-z. Epub 2022 Apr 22. Clin Oral Investig. 2022. PMID: 35449246
-
Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.J Bone Oncol. 2013 Jan 1;2(1):38-46. doi: 10.1016/j.jbo.2012.12.001. eCollection 2013 Feb. J Bone Oncol. 2013. PMID: 26909271 Free PMC article. Review.
-
Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review.Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21(2):e250-9. doi: 10.4317/medoral.20963. Med Oral Patol Oral Cir Bucal. 2016. PMID: 26827065 Free PMC article. Review.
-
Bone-Targeted Therapy.Geburtshilfe Frauenheilkd. 2015 Jun;75(6):584-587. doi: 10.1055/s-0035-1546151. Geburtshilfe Frauenheilkd. 2015. PMID: 26166839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
